Comment by
Biobob on Oct 12, 2022 7:50am
Well it's news about the target being a good target and about being eager about getting the 1b trial results. At least the Cancer meeting will raise awareness but it's not what is expected as usual... we will see what the market thinks at 9:30....
Comment by
Joemare on Oct 12, 2022 7:54am
Unfortunately, nothing much here. So, no clinical data prior to tomorrow. IMHO, delays, extensions, and lack of executive leadership is at play here. Let's wait and see what they will tell us tomorrow................it's not a pleasant situation right now. Executive leadership is at play.
Comment by
Bucknelly21 on Oct 12, 2022 8:10am
I mean is this is all they have at this point? Trying to still sell people on the idea sort is a good thing to target.... give us something worthwhile for once....